Splenic Embolization for Portal Hypertension

Status Withdrawn

Clinical Trial Summary

The primary purpose of this study is to evaluate the safety and efficacy of partial splenic artery embolization in the treatment of symptomatic portal vein hypertension. A secondary aim is to evaluate the relative efficacy of two separate splenic artery embolization techniques, coiling versus particle embolization of the spleen. These two methods will be compared to standard medical management which consist of pain management and fluid draining.

Clinical Trial Description

This is a single center phase I/II study that is designed to assess the safety and efficacy of splenic artery embolization in the setting of symptomatic portal hypertension. All participating investigators have signed the protocol agreement and no investigator will be added until they sign the agreement. The study will not be initiated until FDA and IRB approval is obtained. The study will consist of a 4 week screening period, day of treatment, and 12-month follow-up period. 60 subjects will be enrolled, with a goal of randomizing 30, at the University of Minnesota Medical Center. Enrollment is expected to take up to 48 months. The collection of data will be accomplished by utilizing a clinical research team that will obtain symptomatic portal hypertension improvement and safety assessments. Efficacy assessments will include; change in portal vein velocity, ascitic fluid production change, reduction in splenic size, and improvement in quality of life (QoL). Safety assessments include subject and investigator reported adverse events, subjective pain, and splenic abscess formation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03532750
Study type	Interventional
Source	University of Minnesota
Contact
Status	Withdrawn
Phase	N/A
Start date	November 1, 2018
Completion date	July 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05052892` - A Novel Spleen-dedicated Stiffness Measured by FibroScan to Evaluate Cirrhotic Portal Hypertension (CHESS2105)
Recruiting	`NCT05251272` - A Combined Model Based on Spleen Stiffness, Liver Stiffness and Platelets for Assessing Portal Hypertension in Compensated Cirrhosis (CHESS2202)
Recruiting	`NCT05928624` - A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients	N/A
Recruiting	`NCT04578301` - Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease
Not yet recruiting	`NCT05515861` - Evaluation of EUS in Preventing Rebleeding After Endoscopic Cyanoacrylate Injection for Gastric Varices	N/A
Recruiting	`NCT02364297` - TIPS in Fundal Variceal Bleeding (the TFB Study)	N/A
Recruiting	`NCT01358123` - Value of Von Willebrand Factor in Portal Hypertension	N/A
Completed	`NCT00493480` - Danish Carvedilol Study in Portal Hypertension	Phase 3
Recruiting	`NCT06266260` - Evaluation of the Performance of Direct Portal Pressure Measurement by Endoscopic Ultrasound in a Large Cohort of Patients With Advanced Chronic Liver Disease of Different Etiologies and Newly Diagnosed Clinically Significant Portal Hypertension (EVADIPP)
Recruiting	`NCT03277651` - Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension	N/A
Active, not recruiting	`NCT03736265` - Carvedilol for Prevention of Esophageal Varices Progression	N/A
Completed	`NCT03451149` - Feasibility And Safety Of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Using A Radiofrequency Guidewire	N/A
Completed	`NCT02994485` - Evaluation Of The Portal Pressure By Doppler Ultrasound In Cirrhotic Patients Before And After Simvastatin	Phase 4
Completed	`NCT01923064` - Injection of Cyanoacrylate+Lipiodol vs Cyanoacrylate+Lauromacrogol in Gastric Varices	N/A
Completed	`NCT01851252` - MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy	Phase 1
Completed	`NCT01551966` - Esophageal Capsule Endoscopy in Children	N/A
Completed	`NCT01456286` - Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension	Phase 2/Phase 3
Completed	`NCT02344719` - Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis	Phase 4
Recruiting	`NCT00414713` - Transfusion Requirements in Gastrointestinal (GI) Bleeding	Phase 4
Completed	`NCT00766805` - Endoscopic Variceal Ligation (EVL)+ Drugs Versus Endoscopic Variceal Ligation (EVL) Alone For Secondary Prophylaxis	N/A